Enzymotec Ltd. Reports Third Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Enzymotec (ENZY) Tops Q3 EPS by 1c; Guides FY15 EPS Above Consensus
November 11, 2015 7:31 AM ESTEnzymotec (NASDAQ: ENZY) reported Q3 EPS of $0.08, $0.01 better than the analyst estimate of $0.07. Revenue for the quarter came in at $12.4 million versus the consensus estimate of $14.21 million.
Third quarter adjusted EBITDA increased 55.3% to $2.7 million*, compared to the third quarter of 2014.
Enzymotec sees... More
